Latin America OTC Drugs Industry Size to touch USD 26.73 billion by 2021 with a growth rate of 7.71%| Market Data Forecast

According to the report Latin America OTC Drugs Industry, published by Market Data Forecast, The Industry in Latin America region has been estimated at USD 18.44 billion in 2016 and is projected to reach USD 26.73 billion by 2021, at a CAGR of 7.71% during the forecast period from 2016 to 2021. Brazil, Mexico and Argentina are the leading contributors to the Latin America OTC drugs Industry

Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a prescription from a healthcare professional, as compared to prescription drugs, which may be sold only to consumers possessing a valid prescription. Some drugs may be legally classified as over-the-counter (i.e. no prescription is required), but may only be dispensed by a pharmacist after an assessment of the patient's needs or the provision of patient education.

Browse Industry data tables and in-depth TOC of the Latin America OTC Drugs Industry to 2021 @ http://www.marketdataforecast.com/market-reports/latin-america-over-the-counter-drugs-market-513/

Increasing adoption of western lifestyles and growing prosperities is leading to increase in Industry size and OTC demand. Promotion and Industrying initiatives will be a key trend for Industry growth in the forecast period for this region. The growing healthcare costs and an increase in the older population demand the need for better accessibility and affordability of healthcare services. Self-medication with non-prescription drugs play an important role in this and help in improving the accessibility and cost-benefits of healthcare services.

GlaxoSmithKline, Johnson and Johnson, Novartis, Bayer, Pfizer, Sanofi and Takeda are the leading companies that contribute to Latin America Industry.

Free sample of the report is available @ http://www.marketdataforecast.com/market-reports/latin-america-over-the-counter-drugs-market-513/request-sample

Key Points from Table of Contents
Overview
• Executive Summary
• Key Inferences
• New Developments
Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
Latin America OTC Drugs Industry: Segmentation
• Product Type
o Analgesics
o Cough, Cold and Flu Products
o Vitamins and Minerals
o Dermatological Products
o Gastrointestinal Products
o Ophthalmic Products
o Sleep Aid Products
o Weight Loss/Diet Products
o Others
• By Formulation Type
o Tablets
o Liquids
o Ointments
o Sprays
• Distribution Channels
o Pharmacies
o SuperIndustrys/HyperIndustrys
o Convenience stores
o Others (Online Drug Stores)
Geographical Analysis
Brazil
Mexico
Argentina
Rest of Latin America
Strategic Analysis
• PESTLE analysis
• Porter’s Five analysis
Industry Leaders' Analysis
Competitive Landscape

Avail discount @ http://www.marketdataforecast.com/market-reports/latin-america-over-the-counter-drugs-market-513/request-discount

About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and sksillset dedicatedly serve clients from various industries and regions.

Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail:abhishek@marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases

Market Data Forecast, Inc.
502, kakatiya's empire,
Jubilee Gardens,
Hyderabad, India.
500081

This release was published on openPR.